UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 187

Sortiert nach

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Annals of oncology, 2015-04, Vol.26 (4), p.709-714

2015

Link zum Volltext

Verfügbarkeit prüfen

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05)

Lung cancer (Amsterdam, Netherlands), 2014-08, Vol.85 (2), p.306-313

2014

Link zum Volltext

Verfügbarkeit prüfen

The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06)

Annals of oncology, 2016-02, Vol.27 (2), p.324-332

2016

Link zum Volltext

Verfügbarkeit prüfen

Resilience and unmet supportive care needs in patients with cancer during early treatment: A descriptive study

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2015-10, Vol.19 (5), p.582-588

2015

Link zum Volltext

Verfügbarkeit prüfen

Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma

Annals of oncology, 2007-07, Vol.18 (7), p.1196-1202

2007

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

British journal of cancer, 2006-04, Vol.94 (8), p.1099-1106

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

Annals of oncology, 2002-10, Vol.13 (10), p.1539-1549

2002

Link zum Volltext

Verfügbarkeit prüfen

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

British journal of cancer, 2001-05, Vol.84 (10), p.1372-1376

2001

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability

British journal of cancer, 2005-09, Vol.93 (6), p.719-729

2005

Link zum Volltext

Verfügbarkeit prüfen

Management of bleeding in palliative care patients in the general internal medicine ward: a systematic review

Annals of medicine and surgery, 2020-02, Vol.50, p.14-23

2020

Link zum Volltext

Verfügbarkeit prüfen

Origin and prognostic value of circulating KRAS mutations in lung cancer patients

Cancer letters, 2007-09, Vol.254 (2), p.265-273

2007

Link zum Volltext

Verfügbarkeit prüfen

Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway

Cell death and differentiation, 2002-09, Vol.9 (9), p.905-914

2002

Link zum Volltext

Verfügbarkeit prüfen

Impact of early prophylactic cranial irradiation with hippocampal avoidance on neurocognitive function in patients with limited disease small cell lung cancer: A multicenter phase II trial (SAKK 15/12)

Annals of oncology, 2018-10, Vol.29, p.viii597-viii597

2018

Link zum Volltext

Verfügbarkeit prüfen

The future is not what it was...and this may well be so!

Revue médicale suisse, 2014-04, Vol.10 (425), p.779

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials

ESMO open, 2022-04, Vol.7 (2), p.100455-100455, Article 100455

2022

Link zum Volltext

Verfügbarkeit prüfen

NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma

Bone marrow transplantation (Basingstoke), 2018-02, Vol.53 (2), p.175-179

2018

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14

ESMO open, 2023-08, Vol.8 (4), p.101595-101595, Article 101595

2023

Link zum Volltext

Verfügbarkeit prüfen

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Leukemia, 2020-10, Vol.34 (10), p.2820-2820

2020

Link zum Volltext

Verfügbarkeit prüfen

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

Annals of oncology, 2008-04, Vol.19 (4), p.739-745

2008

Link zum Volltext

Verfügbarkeit prüfen

Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients

Bone marrow transplantation (Basingstoke), 2015-04, Vol.50 (4), p.573-578

2015

Link zum Volltext

Verfügbarkeit prüfen

Cyclin D1 Overexpression in Bronchial Epithelia of Patients With Lung Cancer Is Associated With Smoking and Predicts Survival

Journal of clinical oncology, 2003-06, Vol.21 (11), p.2085-2093

2003

Link zum Volltext

Verfügbarkeit prüfen

Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study

Annals of oncology, 2004-03, Vol.15 (3), p.511-516

2004

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]

ESMO open, 2022-06, Vol.7 (3), p.100494-100494, Article 100494

2022

Link zum Volltext

Verfügbarkeit prüfen

The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MO AIC, a multicenter cluster-randomized phase III study (SAKK 95/06)

Annals of oncology, 2016-02, Vol.27 (2), p.324-332

2016

Link zum Volltext

Verfügbarkeit prüfen

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)

Annals of oncology, 2006-10, Vol.17 (10), p.1546-1552

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 187

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(155)

Publikationsform

Artikel
(184)
Berichte
(2)
Reviews
(1)

Sprache

Englisch
(166)
Japanisch
(15)
Deutsch
(11)
Französisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(105)
Life Sciences & Biomedicine
(86)
Science & Technology
(86)
Female
(69)
Aged
(65)
Male
(63)
Middle Aged
(61)
Oncology
(61)
Biological And Medical Sciences
(60)
Medical Sciences
(50)
Adult
(48)
Chemotherapy
(26)
Aged, 80 And Over
(25)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(25)
Lung Neoplasms - Drug Therapy
(25)
Lung Neoplasms - Pathology
(25)
Carcinoma, Non-Small-Cell Lung - Pathology
(24)
Neoplasm Staging
(22)
Pharmacology. Drug Treatments
(22)
Antineoplastic Agents
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(34)
Journal Of Clinical Oncology
(19)
Lung Cancer
(14)
British Journal Of Cancer
(11)
Schweizerische Medizinische Wochenschrift
(7)
British Journal Of Haematology
(6)
Revue Médicale Suisse
(6)
Esmo Open
(5)
Leukemia & Lymphoma
(5)
Oncogene
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05)

The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06)

Resilience and unmet supportive care needs in patients with cancer during early treatment: A descriptive study

Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability

Management of bleeding in palliative care patients in the general internal medicine ward: a systematic review

Origin and prognostic value of circulating KRAS mutations in lung cancer patients

Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway

Impact of early prophylactic cranial irradiation with hippocampal avoidance on neurocognitive function in patients with limited disease small cell lung cancer: A multicenter phase II trial (SAKK 15/12)

The future is not what it was...and this may well be so!

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials

NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients

Cyclin D1 Overexpression in Bronchial Epithelia of Patients With Lung Cancer Is Associated With Smoking and Predicts Survival

Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study

Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]

The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MO AIC, a multicenter cluster-randomized phase III study (SAKK 95/06)

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)

Suchergebnisse filtern